NEPHROS INC (NEPH) Stock Fundamental Analysis
NASDAQ:NEPH - US6406714005 - Common Stock
4.28 USD
+0.45 (+11.75%)
Overall NEPH gets a fundamental rating of 5 out of 10. We evaluated NEPH against 128 industry peers in the Machinery industry. NEPH has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, NEPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year NEPH was profitable.
In the past year NEPH had a positive cash flow from operations.
In the past 5 years NEPH reported 4 times negative net income.
NEPH had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of NEPH (10.84%) is better than 85.16% of its industry peers.
NEPH has a Return On Equity of 13.82%. This is in the better half of the industry: NEPH outperforms 70.31% of its industry peers.
NEPH's Return On Invested Capital of 10.62% is fine compared to the rest of the industry. NEPH outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROIC | 10.62% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 7.95%, NEPH is in the better half of the industry, outperforming 63.28% of the companies in the same industry.
NEPH has a Operating Margin (8.01%) which is comparable to the rest of the industry.
NEPH has a better Gross Margin (63.37%) than 98.44% of its industry peers.
NEPH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NEPH is creating some value.
The number of shares outstanding for NEPH remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NEPH has more shares outstanding
NEPH has a worse debt/assets ratio than last year.
2.2 Solvency
NEPH has an Altman-Z score of -3.63. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.63, NEPH is doing worse than 87.50% of the companies in the same industry.
The Debt to FCF ratio of NEPH is 0.01, which is an excellent value as it means it would take NEPH, only 0.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.01, NEPH belongs to the top of the industry, outperforming 92.97% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that NEPH is not too dependend on debt financing.
NEPH has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NEPH outperforms 85.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | -3.63 |
ROIC/WACC1.07
WACC9.93%
2.3 Liquidity
A Current Ratio of 5.41 indicates that NEPH has no problem at all paying its short term obligations.
NEPH has a better Current ratio (5.41) than 92.19% of its industry peers.
NEPH has a Quick Ratio of 4.14. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.14, NEPH belongs to the best of the industry, outperforming 92.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 192.31% over the past year.
The Revenue has grown by 21.18% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)21.18%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%
3.2 Future
NEPH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 5422130327.01% yearly.
The Revenue is expected to grow by 14.70% on average over the next years. This is quite good.
EPS Next Y587989967349491800%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.58%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 35.67, which means the current valuation is very expensive for NEPH.
NEPH's Price/Earnings ratio is a bit more expensive when compared to the industry. NEPH is more expensive than 67.19% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.02. NEPH is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 419.61, the valuation of NEPH can be described as expensive.
Based on the Price/Forward Earnings ratio, NEPH is valued a bit more expensive than the industry average as 71.09% of the companies are valued more cheaply.
NEPH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.66.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.67 | ||
| Fwd PE | 419.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NEPH is valued a bit more expensive than the industry average as 72.66% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, NEPH is valued a bit cheaper than 60.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.72 | ||
| EV/EBITDA | 27.28 |
4.3 Compensation for Growth
NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NEPH's earnings are expected to grow with 5422130327.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NEPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:NEPH (9/8/2025, 12:16:52 PM)
4.28
+0.45 (+11.75%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners44.01%
Inst Owner Change4.01%
Ins Owners10.74%
Ins Owner Change0%
Market Cap45.37M
Analysts82.5
Price Target5.61 (31.07%)
Short Float %0.07%
Short Ratio0.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)629.41%
Min EPS beat(2)178.43%
Max EPS beat(2)1080.39%
EPS beat(4)4
Avg EPS beat(4)438.24%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)205.3%
EPS beat(12)7
Avg EPS beat(12)116.27%
EPS beat(16)9
Avg EPS beat(16)82.79%
Revenue beat(2)2
Avg Revenue beat(2)24.79%
Min Revenue beat(2)18.66%
Max Revenue beat(2)30.93%
Revenue beat(4)3
Avg Revenue beat(4)13.61%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)2.81%
Revenue beat(12)5
Avg Revenue beat(12)1.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.54%
PT rev (1m)15.79%
PT rev (3m)15.79%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-300%
EPS NY rev (1m)300%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.75%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)6.25%
Revenue NY rev (3m)6.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.67 | ||
| Fwd PE | 419.61 | ||
| P/S | 2.72 | ||
| P/FCF | 22.72 | ||
| P/OCF | 22.72 | ||
| P/B | 4.73 | ||
| P/tB | 5.45 | ||
| EV/EBITDA | 27.28 |
EPS(TTM)0.12
EY2.8%
EPS(NY)0.01
Fwd EY0.24%
FCF(TTM)0.19
FCFY4.4%
OCF(TTM)0.19
OCFY4.4%
SpS1.57
BVpS0.91
TBVpS0.78
PEG (NY)0
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROCE | 12.77% | ||
| ROIC | 10.62% | ||
| ROICexc | 20.6% | ||
| ROICexgc | 27.01% | ||
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% | ||
| FCFM | 11.97% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | 668.5 | ||
| Cash Conversion | 135.12% | ||
| Profit Quality | 150.49% | ||
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 | ||
| Altman-Z | -3.63 |
F-Score7
WACC9.93%
ROIC/WACC1.07
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y587989967349491800%
EPS Next 2Y5422130327.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.18%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%
Revenue Next Year24.58%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y197.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1326.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1326.43%
OCF growth 3YN/A
OCF growth 5YN/A